UnitedHealth (UNH) Fair Value: $482
Fair value is $482 per share based on a 5-year DCF projection, 36% upside from the current price of $354.47.
Updated January 22, 2026 · Discounted Cash Flow Analysis
Current Price
$354.47
Jan 22 close
Fair Entry Price
$482
for 10% annual return
Projected Price
$727
by Jan 2031
Your CAGR
17%
if bought today
Earnings grows from $17.6B → $27.1B over 5 years (10% → 7.7% annually)
How we calculated this
Price Projection
Assumptions Behind This Projection
Metric
Earnings
Starting Growth
10%/yr
Growth Decay
5%/yr
Discount Rate
10%/yr
Projection Period
5 years
Terminal Multiple
22x
Shares Change
-2%/yr
Dividend Growth
5%/yr
Adjust Growth Rate
See how assumptions change fair value
Growth
10%
Fair Value
$482
Want to adjust discount rate, projection period, and more?
Try the full DCF calculator3 DCF analyses per week with a free account
Earnings History & Projections
Historical data shows past performance. The green line projects forward from 10% growth, declining to 7.7% by year 5.
Current Earnings
$17.6B
Projected 2031
$27.1B
This projection uses Earnings. In the full calculator, you can project on 7 different metrics including EBITDA, Earnings, Operating Cash Flow, and more.
Try These Stocks Free
Full DCF analysis with no account required, no limits.
GOOG
Alphabet
Try free →
JPM
JPMorgan
Try free →
NVDA
NVIDIA
Try free →
O
Realty Income
Try free →
RY.TO
Royal Bank
Try free →
Want to analyze any stock?
Create a free account for 3 fair value analyses per week on 130,000+ stocks across 70+ exchanges.
Create Free AccountHow We Calculate Fair Value
DCF (Discounted Cash Flow) answers: "If this company keeps growing, what's the most I should pay today?"
Project future earnings
We take UnitedHealth's current Earnings ($17.6B) and compound it at 10%/yr for 5 years. Growth decays by 5% each year (high growth rarely lasts forever). This growth rate is based on historical averages, and you can adjust it in the calculator.
Estimate future stock price
The projected Earnings ($27.1B) divided by future shares (820.8M) gives us Earnings per share. Multiply by a 22x valuation multiple = $727 stock price in 2031. Plus $48.85 in dividends over 5 years.
Discount to today's value
$727 in 5 years isn't worth $727 today. We discount it back at 10%/yr (your required return). We also add the present value of expected dividends over the period. Result: $482 fair entry price. This is the most you should pay today for your target return.
The Full Calculation (for the investing nerds)
Step 1: Project Earnings
- The most recent Earnings is $17.6B
- We project this out 5 years with 10% initial growth and 5% decay rate
- Growth decay means the growth rate shrinks each year: Year 1 grows at 10%, then the rate is multiplied by (1 - 5/100) each subsequent year
- After 5 years of decaying growth, Earnings reaches $27.1B
Step 2: Project Diluted Shares Outstanding
- Current shares outstanding: 908M
- Shares change at -2%/yr (buybacks reduce share count)
- After 5 years: 820.8M shares
Step 3: Calculate Future Stock Price
- Formula: (Future Earnings ÷ Future Shares) × Price Ratio
- Calculation: ($27.1B ÷ 820.8M) × 22 = $727
Step 4: Project Future Dividends
- Current dividend per share: $8.84
- Dividend growth rate: 5%/yr
- Total dividends over 5 years: $48.85
Step 5: Discount to Present Value
- Future stock price: $727 + $48.85 dividends = $776 total
- Discount rate (your required return): 10%/yr
- Discounting back 5 years: $482 fair value today
UNH trades at $354.47. Buying at that price would yield 17% annual return, which is above your 10% target.
Don't agree with these assumptions? That's the point. Use the calculator above to plug in your own growth rate, discount rate, and time horizon. More conservative? Lower the growth rate. Want a bigger safety margin? Increase the discount rate.
The Most Configurable DCF Calculator
Model any scenario across 130,000+ stocks worldwide.
7 Projection Metrics
Free Cash Flow, EBITDA, Earnings, EBIT, Operating Cash Flow, Operating Income, or Book Value. Pick what matters for your analysis.
130,000+ Stocks, 70+ Markets
Not just US stocks. Analyze companies from exchanges worldwide: Canada, UK, Europe, Asia, and more.
Up to 35 Years of Data
View up to 35 years of historical financials from official filings to inform your growth assumptions.
Full Control
Growth decay, share buybacks/dilution, dividend modeling, custom discount rates, 1-10 year projections. Every lever at your fingertips.
3 DCF analyses per week with a free account.
More Fair Value Analyses
Explore DCF valuations for other popular stocks.
AAPL
Apple
View fair value →
ADBE
Adobe
View fair value →
GOOG
View fair value →
MSFT
Microsoft
View fair value →
PYPL
PayPal
View fair value →
TSLA
Tesla
View fair value →
META
Meta
View fair value →
NVO
Novo Nordisk
View fair value →
NVDA
NVIDIA
View fair value →
JD
JD.com
View fair value →
AMZN
Amazon
View fair value →
HIMS
Hims & Hers
View fair value →
DUOL
Duolingo
View fair value →
CRM
Salesforce
View fair value →
PLTR
Palantir
View fair value →
TSM
TSMC
View fair value →
ASML
ASML
View fair value →
UBER
Uber
View fair value →
Frequently Asked Questions
What is UnitedHealth's fair value?
Is UNH undervalued right now?
Why do investors use DCF analysis?
How accurate is DCF analysis?
What makes Stock Unlock's calculator different?
What discount rate should I use?
What's the difference between fair value and price target?
Why use Earnings instead of other metrics?
Disclaimer: This is not financial advice. DCF estimates depend on assumptions that may not reflect actual performance. Do your own research. Stock Unlock is not a brokerage.